Read more

June 17, 2024
1 min read
Save

COVID-19 infection prior to shoulder arthroplasty may increase risk of complications

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Key takeaways:

  • COVID-19 within 30 days prior to shoulder arthroplasty may increase risk of several postoperative complications.
  • Patients with recent COVID-19 infections may benefit from postponing elective TSA procedures.
Perspective from Nickolas G. Garbis, MD

Results showed COVID-19 diagnosis prior to total shoulder arthroplasty was associated with increased risk of sepsis, ED visits, readmissions, periprosthetic fractures, wound infections, thrombosis and revisions at 60 days postoperatively.

Researchers used the TriNetX database to perform a retrospective cohort comparison of 63,768 patients (mean age, 72 years) who underwent TSA between Jan. 1, 2018, and July 1, 2023. Among the cohort, 7,118 patients (11.08%) were diagnosed with COVID-19 within 30 days prior to surgery. Researchers then assessed two propensity-matched cohorts of 6,982 patients with vs. without COVID-19 prior to TSA.

COVID variant
COVID-19 within 30 days prior to shoulder arthroplasty may increase risk of several postoperative complications. Image: Adobe Stock

Patients with a COVID-19 diagnosis prior to TSA had 1.96 times the odds of sepsis (P = .0005), 1.42 times the odds of superficial wound infection (P = .0032), 1.42 times the odds of deep vein thrombosis (P < .0001) and 1.52 times the odds of pulmonary embolism (P = .0001) compared with patients without COVID-19 prior to TSA within 60 days postoperatively.

In addition, patients with a COVID-19 diagnosis prior to TSA had 1.10 times the odds of ED visits (P = .0249), 1.79 times the odds of readmission (P < .0001), 3.10 times the odds of periprosthetic fracture (P < .0001) and 2.87 times the odds of revision (P < .0001) compared with patients without COVID-19 prior to TSA within 60 days postoperatively.

“There may be significant benefit to closer monitoring and greater preventive measures to reduce the occurrence of postoperative complications in this setting,” the researchers wrote in the study. “In addition, patients may benefit from postponing elective TSA procedures in the setting of a recent COVID-19 infection.”